Themes Driving Life Sciences IT Investment in EMEA

This white paper outlines six key themes that influence investment in IT by life sciences companies across Europe, the Middle East, and Africa (EMEA). It discusses how digital advancements present opportunities while increasing cybersecurity risks, particularly noting that 86% of Layer 7 DDoS attacks targeted pharmaceutical companies in this region. The themes include cloud hosting, big data, artificial intelligence, virtual care, mergers and acquisitions, and blockchain technology. Each theme emphasizes the need for secure implementation and adherence to regulations to mitigate risks. The paper also highlights the growing IT budgets in the pharmaceutical sector, with 72% of companies increasing their investments in 2024, driven by trends such as precision medicine. It stresses the importance of integrating cybersecurity measures into digital transformation strategies to prevent costly cyberattacks and operational disruptions. The economic impacts of cyberattacks are detailed, emphasizing the necessity for robust cybersecurity frameworks alongside technological investments.